Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Melora is a prominent Brazilian pharmaceutical company specializing in advanced dermatology and skin care solutions. Operating as a subsidiary of the Spanish multinational Cantabria Labs, the company focuses on the commercialization of high-tech dermo-cosmetic products backed by clinical research. Its portfolio includes globally recognized brands such as Heliocare for photoprotection, Endocare for skin regeneration, and Biretix for acne management. Melora maintains a strong presence in the Brazilian medical community, collaborating closely with dermatologists to provide evidence-based treatments for various skin conditions, including aging, melasma, and sun damage.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Melora do Brasil Produtos Dermatológicos.